35 results on '"Velakoulis, Dennis"'
Search Results
2. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
- Author
-
Baldwin, Helen, Radua, Joaquim, Antoniades, Mathilde, Haas, Shalaila S., Frangou, Sophia, Agartz, Ingrid, Allen, Paul, Andreassen, Ole, Atkinson, Kimberley, Bachman, Peter, Baeza, Inmaculada, Bartholomeusz, Cali F., Chee, Michael W. L., Colibazzi, Tiziano, Cooper, Rebecca E., Corcoran, Cheryl M., Cropley, Vanessa L., Ebdrup, Bjørn H., Fortea, Adriana, Glenthøj, Louise Birkedal, Hamilton, Holly K., Haut, Kristen M., Hayes, Rebecca A., He, Ying, Heekeren, Karsten, Kaess, Michael, Kasai, Kiyoto, Katagiri, Naoyuki, Kim, Minah, Kindler, Jochen, Klaunig, Mallory J., Koike, Shinsuke, Koppel, Alex, Kristensen, Tina D., Bin Kwak, Yoo, Kwon, Jun Soo, Lawrie, Stephen M., Lebedeva, Irina, Lee, Jimmy, Lin, Ashleigh, Loewy, Rachel L., Mathalon, Daniel H., Michel, Chantal, Mizrahi, Romina, Møller, Paul, Nelson, Barnaby, Nemoto, Takahiro, Nordholm, Dorte, Omelchenko, Maria A., Pantelis, Christos, Raghava, Jayachandra M., Røssberg, Jan Ivar, Rössler, Wulf, Salisbury, Dean F., Sasabayashi, Daiki, Schall, Ulrich, Smigielski, Lukasz, Sugranyes, Gisela, Suzuki, Michio, Takahashi, Tsutomu, Tamnes, Christian Krog, Tang, Jinsong, Theodoridou, Anastasia, Thomopoulos, Sophia I., Tomyshev, Alexander S., Uhlhaas, Peter J., Værnes, Tor Gunnar, van Amelsvoort, Therese A. M. J., Van Erp, Theo G. M., Waltz, James A., Westlye, Lars Tjelta, Wood, Stephen J., Zhou, Juan H., McGuire, Philip, Thompson, Paul M., Jalbrzikowski, Maria, Hernaus, Dennis, Fusar-Poli, Paolo, de la Fuente-Sandoval, Camilo, Catalano, Sabrina, Hubl, Daniela, Schiffman, Jason, Venegoni, Enea D., Hooker, Christine I., Rasser, Paul E., Hegelstad, Wenche, Resch, Franz, Lemmers-Jansen, Imke L. J., Amminger, G. Paul, Chen, Xiaogang, Cho, Kang Ik K., Glenthøj, Birte Yding, de Haan, Lieuwe, Harris, Matthew A., Hwang, Wu Jeong, León-Ortiz, Pablo, Ma, Xiaoqian, McGorry, Patrick, Mora-Durán, Ricardo, Mizuno, Masafumi, Nordentoft, Merete, Ouyang, Lijun, Pariente, Jose C., Reyes-Madrigal, Francisco, Sørensen, Mikkel E., Velakoulis, Dennis, Vinogradov, Sophia, Wenneberg, Christina, Yamasue, Hidenori, Yuan, Liu, Yung, Alison R., Lee Kong Chian School of Medicine (LKCMedicine), Institute of Mental Health, Singapore, Adult Psychiatry, APH - Mental Health, Amsterdam Neuroscience - Complex Trait Genetics, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Clinical Developmental Psychology, IBBA, Psychiatry 3, RS: MHeNs - R2 - Mental Health, MUMC+: MA Med Staf Spec Psychiatrie (9), and Psychiatrie & Neuropsychologie
- Subjects
SEGMENTATION ,610 Medicine & health ,SURFACE-BASED ANALYSIS ,Cellular and Molecular Neuroscience ,SDG 3 - Good Health and Well-being ,Medisinske Fag: 700 [VDP] ,SCHIZOPHRENIA ,Humans ,Medicine [Science] ,Biological Psychiatry ,VULNERABILITY ,ABNORMALITIES ,Brain ,BRAIN STRUCTURE ,Brain/diagnostic imaging ,Magnetic Resonance Imaging ,Neuroanatomy ,Psychiatry and Mental health ,Psychotic Disorders ,ULTRA-HIGH RISK ,ONSET ,VOLUME ,Psychotic Disorders/complications ,HUMAN CEREBRAL-CORTEX - Abstract
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profiles and outcome features. However, the extent of neuroanatomical heterogeneity in the CHR-P state is largely undetermined. We aimed to quantify the neuroanatomical heterogeneity in structural magnetic resonance imaging measures of cortical surface area (SA), cortical thickness (CT), subcortical volume (SV), and intracranial volume (ICV) in CHR-P individuals compared with healthy controls (HC), and in relation to subsequent transition to a first episode of psychosis. The ENIGMA CHR-P consortium applied a harmonised analysis to neuroimaging data across 29 international sites, including 1579 CHR-P individuals and 1243 HC, offering the largest pooled CHR-P neuroimaging dataset to date. Regional heterogeneity was indexed with the Variability Ratio (VR) and Coefficient of Variation (CV) ratio applied at the group level. Personalised estimates of heterogeneity of SA, CT and SV brain profiles were indexed with the novel Person-Based Similarity Index (PBSI), with two complementary applications. First, to assess the extent of within-diagnosis similarity or divergence of neuroanatomical profiles between individuals. Second, using a normative modelling approach, to assess the 'normativeness' of neuroanatomical profiles in individuals at CHR-P. CHR-P individuals demonstrated no greater regional heterogeneity after applying FDR corrections. However, PBSI scores indicated significantly greater neuroanatomical divergence in global SA, CT and SV profiles in CHR-P individuals compared with HC. Normative PBSI analysis identified 11 CHR-P individuals (0.70%) with marked deviation (>1.5 SD) in SA, 118 (7.47%) in CT and 161 (10.20%) in SV. Psychosis transition was not significantly associated with any measure of heterogeneity. Overall, our examination of neuroanatomical heterogeneity within the CHR-P state indicated greater divergence in neuroanatomical profiles at an individual level, irrespective of psychosis conversion. Further large-scale investigations are required of those who demonstrate marked deviation. Published version HB is funded by a National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre doctoral studentship. SF is supported by the National Institute of Mental Health under grant R01MH113619. CMC is supported by R01MH107558 and R01MH115332. BN is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (1137687). AL is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (#1148793). CKT is supported by the Research Council of Norway (223273, 288083, 323951) and the South-Eastern Norway Regional Health Authority (2019069, 2021070, 500189). PMT is supported by NIH grants R01MH116147, P41EB015922, and R01AG058854. VC is supported by a National Health and Medical Research Council (NHMRC) Investigator Grant (1177370). LTW is supported by the European Research Council under the European Union’s Horizon 2020 research and Innovation program (ERC StG, Grant 802998). GS is supported by the Fundació Clínic Recerca Biomèdica, the Brain and Behavior Research Foundation (NARSAD Young Investigator Award 2017, grant ID: 26731), the Alicia Koplowitz Foundation and the Spanish Ministry of Health, Instituto de Salud Carlos III “Health Research Fund” (PI15/0444; PI18/0242; PI18/00976). CF-S was supported by grants 182279 and 261895 from the Consejo Nacional de Ciencia y Tecnología, grants from CONACYT’s Sistema Nacional de Investigadores, and grant R21 MH117434 from the National Institutes of Health. CP was supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship (1105825), an NHMRC L3 Investigator Grant (1196508), and NHMRC Program Grant (ID: 1150083). Core funding for ENIGMA was provided by the NIH Big Data to Knowledge (BD2K) program under consortium grant U54 EB020403 to PMT.
- Published
- 2022
3. Personality profiles in patients with epileptic seizures and patients with psychogenic non-epileptic seizures
- Author
-
Leong, Michelle, De Wei Wang, Albert, Trainor, David, Johnstone, Ben, Rayner, Genevieve, Kalincik, Tomas, Kwan, Patrick, O’Brien, Terence, Velakoulis, Dennis, and Malpas, Charles
- Published
- 2022
- Full Text
- View/download PDF
4. Mood disorder screening tests among patients with seizure disorders
- Author
-
Holper, Sarah, Foster, Emma, Lloyd, Michael, Rayner, Genevieve, Winton-Brown, Tobias, Velakoulis, Dennis, O'Brien, Terence, Kwan, Patrick, and Malpas, Charles
- Published
- 2022
- Full Text
- View/download PDF
5. Factors associated with subjective cognitive function in epilepsy: a real-world analysis
- Author
-
Ye, Karena, Foster, Emma, Johnson, Benjamin, Carney, Patrick, Velakoulis, Dennis, O’Brien, Terence, Kwan, Patrick, and Malpas, Charles
- Published
- 2022
- Full Text
- View/download PDF
6. Psychopathology profiles in patients with epileptic seizures compared to non-epileptic psychogenic seizures
- Author
-
De Wei Wang, Albert, Leong, Michelle, Johnstone, Benjamin, Rayner, Genevieve, Kalincik, Tomas, Kwan, Patrick, O’Brien, Terence, Velakoulis, Dennis, and Malpas, Charles
- Published
- 2022
- Full Text
- View/download PDF
7. Predictors of patient-reported antiseizure medication-related adverse events: a real-world analysis
- Author
-
Dang, Yew-Li, Foster, Emma, Lloyd, Michael, Rayner, Genevieve, Rychkova, Maria, Ali, Rashida, Carney, Patrick, Velakoulis, Dennis, Winton-Brown, Tobias, Kalincik, Tomas, Perucca, Piero, O’Brien, Terence, Kwan, Patrick, and Malpas, Charles
- Published
- 2022
- Full Text
- View/download PDF
8. Anti-epileptic drugs (AEDs) and cognition in patients undergoing investigation for epilepsy and related disorders
- Author
-
Foster, Emma, Ye, Karena, Carney, Patrick, Johnstone, Ben, Velakoulis, Dennis, O’Brien, Terence, Kwan, Patrick, and Malpas, Charles
- Published
- 2022
- Full Text
- View/download PDF
9. A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia
- Author
-
Vivash, Lucy, Malpas, Charles B, Meletis, Christian, Gollant, Meghan, Eratne, Dhamidhu, Li, Qiao-Xin, McDonald, Stuart, O'Brien, William T, Brodtmann, Amy, Darby, David, Kyndt, Christopher, Walterfang, Mark, Hovens, Christopher M, Velakoulis, Dennis, and O'Brien, Terence J
- Subjects
110999 Neurosciences not elsewhere classified ,FOS: Clinical medicine ,110399 Clinical Sciences not elsewhere classified - Abstract
Introduction: Sodium selenate increases tau dephosphorylation through protein phosphatase 2 activation. Here we report an open-label Phase 1b study of sodium selenate as a disease-modifying treatment for behavioral variant frontotemporal dementia (bvFTD). Methods: Twelve participants with bvFTD received sodium selenate (15 mg, three times a day) for 52 weeks. Safety assessments were carried out throughout the trial. Primary outcomes were frequency of adverse events (AEs), serious adverse events (SAEs), and discontinuations. Secondary outcomes of potential efficacy included cognitive and behavioral assessments, magnetic resonance imaging (MRI) whole brain volume, and cerebrospinal fluid (CSF) and blood total tau (t-tau), phosphorylated tau (p-tau), and neurofilament light (NfL) levels, which were measured at baseline and at week 52. Results: Sodium selenate was safe and well tolerated. All participants completed the study, and the majority (64.7%) of reported AEs were mild. One SAE occurred, which was not treatment related. Small declines in MRI and cognitive and behavioral measures were observed over the treatment period. There was no evidence for change in CSF protein levels (t-tau, p-tau, or NfL). Further analysis showed two distinct groups when measuring disease progression markers over the course of the study-one (n = 4) with substantial brain atrophy (2.5% to 6.5% reduction) and cognitive and behavioral decline over the 12-month treatment period, and the second group (n = 7) with no detectable change in cognitive and behavioral measures and less brain atrophy (0.3% to 1.7% reduction). Conclusion: Sodium selenate is safe and well tolerated in patients with bvFTD. Randomized-controlled trials are warranted to investigate potential efficacy.
- Published
- 2022
- Full Text
- View/download PDF
10. sj-docx-1-anp-10.1177_00048674221080709 ��� Supplemental material for Clinico-demographics of people with younger-onset dementia and neuropsychiatric symptoms referred to an Australian dementia support service: A comparison study with older-onset dementia
- Author
-
Loi, Samantha M, Atee, Mustafa, Morris, Thomas, Whiting, Daniel, Macfarlane, Stephen, Cunningham, Colm, and Velakoulis, Dennis
- Subjects
FOS: Psychology ,FOS: Clinical medicine ,mental disorders ,170199 Psychology not elsewhere classified ,110319 Psychiatry (incl. Psychotherapy) ,Neuroscience - Abstract
Supplemental material, sj-docx-1-anp-10.1177_00048674221080709 for Clinico-demographics of people with younger-onset dementia and neuropsychiatric symptoms referred to an Australian dementia support service: A comparison study with older-onset dementia by Samantha M Loi, Mustafa Atee, Thomas Morris, Daniel Whiting, Stephen Macfarlane, Colm Cunningham and Dennis Velakoulis in Australian & New Zealand Journal of Psychiatry
- Published
- 2022
- Full Text
- View/download PDF
11. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning: Dementia Praecox Revisited
- Author
-
Koutsouleris, Nikolaos, Pantelis, Christos, Kambeitz, Joseph, Toivonen, Anna, Turtonen, Otto, Botterweck, Sonja, Kluthausen, Norman, Antoch, Gerald, Caspers, Julian, Wittsack, Hans-Jörg, Blasi, Giuseppe, Pergola, Giulio, Caforio, Grazia, Salokangas, Raimo K R, Fazio, Leonardo, Quarto, Tiziana, Gelao, Barbara, Romano, Raffaella, Andriola, Ileana, Falsetti, Andrea, Barone, Marina, Passiatore, Roberta, Sangiuliano, Marina, Surmann, Marian, Hietala, Jarmo, Bienek, Olga, Dannlowski, Udo, Solana, Ana Beatriz, Abraham, Manuela, Schirmer, Timo, Ferro, Adele, Re, Marta, Sberna, Maurizio, D'Agostino, Armando, Del Fabro, Lorenzo, Bertolino, Alessandro, Perna, Giampaolo, Nobile, Maria, Balestrieri, Matteo, Bonivento, Carolina, Cabras, Giuseppe, Fabbro, Franco, Delvecchio, Giuseppe, Maggioni, Eleonora, Squarcina, Letizia, Gritti, Davide, Brambilla, Paolo, Rossetti, Maria Gloria, Ferrari, Raffaele, Hernandez, Dena Michelle Godwin, Nalls, Michael, Rohrer, Jonathan, Ramasamy, Adaikalavan, Kwok, John, Dobson-Stone, Carol, Brooks, William, Schofield, Peter, Upthegrove, Rachel, Halliday, Glenda, Hodges, John, Piguet, Olivier, Bartley, Lauren, Thompson, Elizabeth, Hernández, Isabel, Ruiz, Agustín, Boada, Mercè, Borroni, Barbara, Padovani, Alessandro, Wood, Stephen J, Cruchaga, Carlos, Cairns, Nigel, Benussi, Luisa, Binetti, Giuliano, Ghidoni, Roberta, Forloni, Gianluigi, Albani, Diego, Galimberti, Daniela, Fenoglio, Chiara, Serpente, Maria, Lencer, Rebekka, Scarpini, Elio, Clarimón, Jordi, Lleó, Alberto, Blesa, Rafael, Landqvist Waldö, Maria, Nilsson, Karin, Nilsson, Christer, Mackenzie, Ian R.A., Hsiung, Ging-Yuek, Mann, David, Borgwardt, Stefan, Grafman, Jordan, Morris, Christopher, Attems, Johannes, McKeith, Ian, Thomas, Alan, Pietrini, Pietro, Huey, Edward, Wassermann, Eric, Baborie, Atik, Jaros, Evelyn, Maj, Carlo, Tierney, Michael, Pastor, Pau, Razquin, Cristina, Ortega-Cubero, Sara, Alonso, Elena, Perneczky, Robert, Alexopoulos, Panagiotis, Kurz, Alexander, Rainero, Innocenzo, Rubino, Elisa, Velakoulis, Dennis, Nöthen, Markus M., Pinessi, Lorenzo, Rogaeva, Ekaterina, George-Hyslop, Peter, Rossi, Giacomina, Tagliavini, Fabrizio, Giaccone, Giorgio, Rowe, James, Schlachetzki, Johannes, Uphill, James, Collinge, John, Degenhardt, Franziska, Mead, Simon, Van Deerlin, Vivianna, Marschhauser, Anke, Regenbrecht, Frank, Thoene-Otto, Angelika, Gordulla, Jannis, Ballarini, Tommaso, Engel, Annerose, Pino, Daniele, Leuthold, Dominique, Polyakova, Maryna, Naumann, Heike, Grossman, Murray, Trojanowski, John Q, van der Zee, Julie, Van Broeckhofen, Christine, Cappa, Stefano F, Le Ber, Isabelle, Hannequin, Didier, Golfier, Véronique, Vercelletto, Martine, Mueller, Karsten, Brice, Alexis, Nacmias, Benedetta, Sorbi, Sandro, Bagnoli, Silvia, Piaceri, Irene, Nielsen, Jørgen E, Hjermind, Lena E, Riemenschneider, Matthias, Mayhaus, Manuel, Ibach, Bernd, Villringer, Arno, Gasparoni, Gilles, Pichler, Sabrina, Gu, Wei, Rossor, Martin N, Fox, Nick C, Warren, Jason D, Spillantini, Maria Grazia, Morris, Huw R, Rizzu, Patrizia, Heutink, Peter, Danek, Adrian, Snowden, Julie S, Rollinson, Sara, Richardson, Anna, Gerhard, Alexander, Bruni, Amalia C, Maletta, Raffaele, Frangipane, Francesca, Cupidi, Chiara, Bernardi, Livia, Anfossi, Maria, Fassbender, Klaus, Gallo, Maura, Conidi, Maria Elena, Smirne, Nicoletta, Rademakers, Rosa, Baker, Matt, Dickson, Dennis W, Graff-Radford, Neill R, Petersen, Ronald C, Knopman, David S, Josephs, Keith A, Fliessbach, Klaus, Boeve, Bradley F, Parisi, Joseph E, Seeley, William W, Miller, Bruce L, Karydas, Anna M, Rosen, Howard, van Swieten, John C, Dopper, Elise Gp, Seelaar, Harro, Pijnenburg, Yolande Al, Jahn, Holger, Scheltens, Philip, Logroscino, Giancarlo, Capozzo, Rosa, Novelli, Valeria, Puca, Annibale A, Franceschi, Massimo, Postiglione, Alfredo, Milan, Graziella, Sorrentino, Paolo, Kristiansen, Mark, Kornhuber, Johannes, Chiang, Huei-Hsin, Graff, Caroline, Pasquier, Florence, Rollin, Adeline, Deramecourt, Vincent, Lebouvier, Thibaud, Kapogiannis, Dimitrios, Ferrucci, Luigi, Pickering-Brown, Stuart, Singleton, Andrew B, McGuire, Philip, Landwehrmeyer, Bernhard, Hardy, John, Momeni, Parastoo, Barthel, Henryk, Elisa, Semler, Jolina, Lombardi, Christine, von Arnim, Felix, Oberahauser, Kai, Schumacher, Jan, Lehmbeck, Juan-Manuel, Maler, Anderl-Straub, Sarah, Tanja, Richter-Schmidinger, Anke, Hammer-Kaspereit, Timo, Oberstein, Felix, Müller-Sarnowski, Carola, Roßmeier, Albert, Ludolph, Jan, Kassubek, Anja, Schneider, Johannes, Levin, Prudlo, Johannes, Synofzik, Matthis, Wiltfang, Jens, Riedl, Lina, Diehl-Schmid, Janine, Otto, Markus, Meisenzahl, Eva, Falkai, Peter, Dwyer, Dominic B, Schroeter, Matthias L, Consortium, the PRONIA, Haas, Shalaila, Hasan, Alkomiet, Hoff, Claudius, Khanyaree, Ifrah, Melo, Aylin, Muckenhuber-Sternbauer, Susanna, Köhler, Yanis, Urquijo-Castro, Maria-Fernanda, Öztürk, Ömer, Penzel, Nora, Rangnick, Adrian, von Saldern, Sebastian, Spangemacher, Moritz, Tupac, Ana, Weiske, Johanna, Wosgien, Antonia, Krämer, Camilla, Blume, Karsten, Paul, Riya, Hedderich, Dennis, Julkowski, Dominika, Kaiser, Nathalie, Lichtenstein, Thorsten, Milz, Ruth, Nikolaides, Alexandra, Pilgram, Tanja, Seves, Mauro, Wassen, Martina, Andreou, Christina, Dong, Sen, Egloff, Laura, Harrisberger, Fabienne, Heitz, Ulrike, Lenz, Claudia, Leanza, Letizia, Mackintosh, Amatya, Smieskova, Renata, Studerus, Erich, Walter, Anna, Widmayer, Sonja, Popovic, David, Day, Chris, Lowri Griffiths, Sian, Iqbal, Mariam, Pelton, Mirabel, Mallikarjun, Pavan, Stainton, Alexandra, Lin, Ashleigh, Lalousis, Paris, Denissoff, Alexander, Ellilä, Anu, Oeztuerk, Oemer, From, Tiina, Heinimaa, Markus, Ilonen, Tuula, Jalo, Päivi, Laurikainen, Heikki, Luutonen, Antti, Mäkela, Akseli, Paju, Janina, Pesonen, Henri, Säilä, Reetta-Liina, International FTD-Genetics Consortium (IFGC), German Frontotemporal Lobar Degeneration (FTLD) Consortium, PRONIA Consortium, and International FTD-Genetics Consortium Consortium
- Subjects
Adult ,Male ,Medizin ,genetics [Alzheimer Disease] ,genetics [Psychotic Disorders] ,Neuropsychological Tests ,diagnostic imaging [Frontotemporal Dementia] ,diagnostic imaging [Psychotic Disorders] ,Machine Learning ,methods [Magnetic Resonance Imaging] ,Brain ,Female ,Humans ,Magnetic Resonance Imaging ,Alzheimer Disease ,Frontotemporal Dementia ,Psychotic Disorders ,Schizophrenia ,pathology [Brain] ,genetics [Schizophrenia] ,ddc:610 ,diagnostic imaging [Brain] ,genetics [Frontotemporal Dementia] ,Settore MED/25 - Psichiatria ,Psychiatry and Mental health ,diagnostic imaging [Schizophrenia] ,diagnostic imaging [Alzheimer Disease] - Abstract
Weitere Nicht-UDE Autoren sind nicht genannt. Importance: The behavioral and cognitive symptoms of severe psychotic disorders overlap with those seen in dementia. However, shared brain alterations remain disputed, and their relevance for patients in at-risk disease stages has not been explored so far. Objective: To use machine learning to compare the expression of structural magnetic resonance imaging (MRI) patterns of behavioral-variant frontotemporal dementia (bvFTD), Alzheimer disease (AD), and schizophrenia; estimate predictability in patients with bvFTD and schizophrenia based on sociodemographic, clinical, and biological data; and examine prognostic value, genetic underpinnings, and progression in patients with clinical high-risk (CHR) states for psychosis or recent-onset depression (ROD). Design, Setting, and Participants: This study included 1870 individuals from 5 cohorts, including (1) patients with bvFTD (n = 108), established AD (n = 44), mild cognitive impairment or early-stage AD (n = 96), schizophrenia (n = 157), or major depression (n = 102) to derive and compare diagnostic patterns and (2) patients with CHR (n = 160) or ROD (n = 161) to test patterns' prognostic relevance and progression. Healthy individuals (n = 1042) were used for age-related and cohort-related data calibration. Data were collected from January 1996 to July 2019 and analyzed between April 2020 and April 2022. Main Outcomes and Measures: Case assignments based on diagnostic patterns; sociodemographic, clinical, and biological data; 2-year functional outcomes and genetic separability of patients with CHR and ROD with high vs low pattern expression; and pattern progression from baseline to follow-up MRI scans in patients with nonrecovery vs preserved recovery. Results: Of 1870 included patients, 902 (48.2%) were female, and the mean (SD) age was 38.0 (19.3) years. The bvFTD pattern comprising prefrontal, insular, and limbic volume reductions was more expressed in patients with schizophrenia (65 of 157 [41.2%]) and major depression (22 of 102 [21.6%]) than the temporo-limbic AD patterns (28 of 157 [17.8%] and 3 of 102 [2.9%], respectively). bvFTD expression was predicted by high body mass index, psychomotor slowing, affective disinhibition, and paranoid ideation (R2= 0.11). The schizophrenia pattern was expressed in 92 of 108 patients (85.5%) with bvFTD and was linked to the C9orf72 variant, oligoclonal banding in the cerebrospinal fluid, cognitive impairment, and younger age (R2= 0.29). bvFTD and schizophrenia pattern expressions forecasted 2-year psychosocial impairments in patients with CHR and were predicted by polygenic risk scores for frontotemporal dementia, AD, and schizophrenia. Findings were not associated with AD or accelerated brain aging. Finally, 1-year bvFTD/schizophrenia pattern progression distinguished patients with nonrecovery from those with preserved recovery. Conclusions and Relevance: Neurobiological links may exist between bvFTD and psychosis focusing on prefrontal and salience system alterations. Further transdiagnostic investigations are needed to identify shared pathophysiological processes underlying the neuroanatomical interface between the 2 disease spectra.
- Published
- 2022
12. Clinical, brain, and multilevel clustering in early psychosis and affective stages
- Author
-
Dwyer, Dominic B., Buciuman, Madalina-Octavia, Ruef, Anne, Kambeitz, Joseph, Sen Dong, Mark, Stinson, Caedyn, Kambeitz-Ilankovic, Lana, Degenhardt, Franziska, Sanfelici, Rachele, Antonucci, Linda A., Lalousis, Paris Alexandros, Wenzel, Julian, Urquijo-Castro, Maria Fernanda, Popovic, David, Oeztuerk, Oemer Faruk, Haas, Shalaila S., Weiske, Johanna, Hauke, Daniel, Neufang, Susanne, Schmidt-Kraepelin, Christian, Ruhrmann, Stephan, Penzel, Nora, Lichtenstein, Theresa, Rosen, Marlene, Chisholm, Katharine, Riecher-Rössler, Anita, Egloff, Laura, Schmidt, André, Andreou, Christina, Hietala, Jarmo, Schirmer, Timo, Romer, Georg, Michel, Chantal, Rössler, Wulf, Maj, Carlo, Borisov, Oleg, Krawitz, Peter M., Falkai, Peter, Pantelis, Christos, Lencer, Rebekka, Bertolino, Alessandro, Borgwardt, Stefan, Noethen, Markus, Brambilla, Paolo, Schultze-Lutter, Frauke, Meisenzahl, Eva, Wood, Stephen J., Davatzikos, Christos, Upthegrove, Rachel, Salokangas, Raimo K. R., Koutsouleris, Nikolaos, Mackintosh, Amatya, Kaiser, Nathalie, Lichtenstein, Thorsten, Seves, Mauro, Chisholm, Katie, Reniers, Renate, Stainton, Alexandra, From, Tiina, Heinimaa, Markus, Ilonen, Tuula, Jalo, Päivi, Laurikainen, Heikki, Tuominen, Lauri, Luutonen, Sinikka, Paju, Janina, Tikka, Maria, Armio (Säilä), Reetta-Liina, Toivonen, Anna, Walta, Maija, Fabbro, Franco, Balestrieri, Matteo, Bonivento, Carolina, Garzitto, Marco, Cabras, Giuseppe, Piccin, Sara, Castellani, Umberto, Bellani, Marcella, Maieron, Marta, Girometti, Rossano, Zuiani, Chiara, Skafidas, Stan, Velakoulis, Dennis, Everall, Ian, Merritt, Antonia, Jovicevic, Michael, Plicht, Manuel, Bequé, Dirk, Solana Sánchez, Ana Beatriz, Hehn, Nicolas, Herrmann, Katrin, Burke, Michael X., Fernandez, Brice, Altamura, Carlo, Rango, Mario, Ferro, Adele, Belleri, Marika, Maggioni, Eleonora, Squarcina, Letizia, Re, Marta, Delvecchio, Giuseppe, Meneghelli, Anna, Monzani, Emiliano, Sassi, Roberto, Sberna, Maurizio, Gennari, Luciana, Torremante, Patrizia, Surmann, Marian, Dannlowski, Udo, Bienek, Olga, Blasi, Giuseppe, Pergola, Giulio, Quarto, Tiziana, Andriola, Ileana, Romano, Raffaella, Gelao, Barbara, Fazio, Leonardo, Korda, Alexandra, Rohner, Henrik, Mann, Matthias, Geyer, Phillip, Treit, Peter, Müller, Johannes, Frackowiak, Richard, Wasserman, Danuta, Maier, Wolfgang, Binder, Elisabeth, Woopen, Christiane, Spranger, Tade Matthias, Möhrmann, Karl-Heinz, and PRONIA Consortium
- Subjects
Adult ,Male ,Psychiatry and Mental health ,Psychotic Disorders ,Schizophrenia ,Medizin ,Brain ,Cluster Analysis ,Humans ,Female ,Longitudinal Studies ,610 Medizin und Gesundheit ,Original Investigation - Abstract
Importance Approaches are needed to stratify individuals in early psychosis stages beyond positive symptom severity to investigate specificity related to affective and normative variation and to validate solutions with premorbid, longitudinal, and genetic risk measures. Objective To use machine learning techniques to cluster, compare, and combine subgroup solutions using clinical and brain structural imaging data from early psychosis and depression stages. Design, Setting, and Participants A multisite, naturalistic, longitudinal cohort study (10 sites in 5 European countries; including major follow-up intervals at 9 and 18 months) with a referred patient sample of those with clinical high risk for psychosis (CHR-P), recent-onset psychosis (ROP), recent-onset depression (ROD), and healthy controls were recruited between February 1, 2014, to July 1, 2019. Data were analyzed between January 2020 and January 2022. Main Outcomes and Measures A nonnegative matrix factorization technique separately decomposed clinical (287 variables) and parcellated brain structural volume (204 gray, white, and cerebrospinal fluid regions) data across CHR-P, ROP, ROD, and healthy controls study groups. Stability criteria determined cluster number using nested cross-validation. Validation targets were compared across subgroup solutions (premorbid, longitudinal, and schizophrenia polygenic risk scores). Multiclass supervised machine learning produced a transferable solution to the validation sample. Results There were a total of 749 individuals in the discovery group and 610 individuals in the validation group. Individuals included those with CHR-P (n = 287), ROP (n = 323), ROD (n = 285), and healthy controls (n = 464), The mean (SD) age was 25.1 (5.9) years, and 702 (51.7%) were female. A clinical 4-dimensional solution separated individuals based on positive symptoms, negative symptoms, depression, and functioning, demonstrating associations with all validation targets. Brain clustering revealed a subgroup with distributed brain volume reductions associated with negative symptoms, reduced performance IQ, and increased schizophrenia polygenic risk scores. Multilevel results distinguished between normative and illness-related brain differences. Subgroup results were largely validated in the external sample. Conclusions and Relevance The results of this longitudinal cohort study provide stratifications beyond the expression of positive symptoms that cut across illness stages and diagnoses. Clinical results suggest the importance of negative symptoms, depression, and functioning. Brain results suggest substantial overlap across illness stages and normative variation, which may highlight a vulnerability signature independent from specific presentations. Premorbid, longitudinal, and genetic risk validation suggested clinical importance of the subgroups to preventive treatments.
- Published
- 2022
13. The ENIGMA‐Epilepsy working group: Mapping disease from large data sets
- Author
-
Sisodiya, Sanjay M., Whelan, Christopher D., Hatton, Sean N., Huynh, Khoa, Altmann, Andre, Ryten, Mina, Vezzani, Annamaria, Caligiuri, Maria Eugenia, Labate, Angelo, Gambardella, Antonio, Ives‐Deliperi, Victoria, Meletti, Stefano, Munsell, Brent C., Bonilha, Leonardo, Tondelli, Manuela, Rebsamen, Michael, Rummel, Christian, Vaudano, Anna Elisabetta, Wiest, Roland, Balachandra, Akshara R., Bargalló, Núria, Bartolini, Emanuele, Bernasconi, Andrea, Bernasconi, Neda, Bernhardt, Boris, Caldairou, Benoit, Carr, Sarah J.A., Cavalleri, Gianpiero L., Cendes, Fernando, Concha, Luis, Desmond, Patricia M., Domin, Martin, Duncan, John S., Focke, Niels K., Guerrini, Renzo, Hamandi, Khalid, Jackson, Graeme D., Jahanshad, Neda, Kälviäinen, Reetta, Keller, Simon S., Kochunov, Peter, Kowalczyk, Magdalena A., Kreilkamp, Barbara A.K., Kwan, Patrick, Lariviere, Sara, Lenge, Matteo, Lopez, Seymour M., Martin, Pascal, Mascalchi, Mario, Moreira, José C.V., Morita‐Sherman, Marcia E., Pardoe, Heath R., Pariente, Jose C., Raviteja, Kotikalapudi, Rocha, Cristiane S., Rodríguez‐Cruces, Raúl, Seeck, Margitta, Semmelroch, Mira K.H.G., Sinclair, Benjamin, Soltanian‐Zadeh, Hamid, Stein, Dan J., Striano, Pasquale, Taylor, Peter N., Thomas, Rhys H., Thomopoulos, Sophia I., Velakoulis, Dennis, Vivash, Lucy, Weber, Bernd, Yasuda, Clarissa Lin, Zhang, Junsong, Thompson, Paul M., McDonald, Carrie R., Abela, Eugenio, Absil, Julie, Adams, Sophia, Alhusaini, Saud, Alvim, Marina, Balestrini, Simona, Bender, Benjamin, Bergo, Felipe, Bernardes, Tauana, Calvo, Anna, Carreno, Mar, Cherubini, Andrea, David, Philippe, Davoodi‐Bojd, Esmaeil, Delanty, Norman, Depondt, Chantal, Devinsky, Orrin, Doherty, Colin, França, Wendy Caroline, Franceschet, Leticia, Hibar, Derrek P., Ishikawa, Akari, Kaestner, Erik, Langner, Soenke, Liu, Min, Mirandola, Laura, Naylor, Jillian, Nazem‐Zadeh, Mohammad‐reza, O'Brien, Terence J., Ribeiro, Letícia F., Richardson, Mark, Rosenow, Felix, Severino, Mariasavina, Shuai, Chen, Tortora, Domenico, von Podewils, Felix, Vos, Sjoerd B., Wagner, Jan, and Zhang, Guohao
- Subjects
Connectomics ,Disease ,Review Article ,rsfMRI ,050105 experimental psychology ,03 medical and health sciences ,Epilepsy ,0302 clinical medicine ,Neuroimaging ,quantitative ,Medical imaging ,medicine ,0501 psychology and cognitive sciences ,Radiology, Nuclear Medicine and imaging ,genetics ,Review Articles ,Cognitive science ,Radiological and Ultrasound Technology ,Resting state fMRI ,event-based modeling ,covariance ,deep learning ,DTI ,gene expression ,imaging ,MRI ,05 social sciences ,event‐based modeling ,medicine.disease ,Neurology ,Epilepsy syndromes ,Neurology (clinical) ,Anatomy ,Age of onset ,030217 neurology & neurosurgery - Abstract
Epilepsy is a common and serious neurological disorder, with many different constituent conditions characterized by their electro clinical, imaging, and genetic features. MRI has been fundamental in advancing our understanding of brain processes in the epilepsies. Smaller‐scale studies have identified many interesting imaging phenomena, with implications both for understanding pathophysiology and improving clinical care. Through the infrastructure and concepts now well‐established by the ENIGMA Consortium, ENIGMA‐Epilepsy was established to strengthen epilepsy neuroscience by greatly increasing sample sizes, leveraging ideas and methods established in other ENIGMA projects, and generating a body of collaborating scientists and clinicians to drive forward robust research. Here we review published, current, and future projects, that include structural MRI, diffusion tensor imaging (DTI), and resting state functional MRI (rsfMRI), and that employ advanced methods including structural covariance, and event‐based modeling analysis. We explore age of onset‐ and duration‐related features, as well as phenomena‐specific work focusing on particular epilepsy syndromes or phenotypes, multimodal analyses focused on understanding the biology of disease progression, and deep learning approaches. We encourage groups who may be interested in participating to make contact to further grow and develop ENIGMA‐Epilepsy.
- Published
- 2020
14. sj-pdf-1-anp-10.1177_00048674211058684 ��� Supplemental material for Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
- Author
-
Eratne, Dhamidhu, Janelidze, Shorena, Malpas, Charles B, Loi, Samantha, Walterfang, Mark, Merritt, Antonia, Diouf, Ibrahima, Blennow, Kaj, Zetterberg, Henrik, Cilia, Brandon, Wannan, Cassandra, Bousman, Chad, Everall, Ian, Zalesky, Andrew, Jayaram, Mahesh, Thomas, Naveen, Berkovic, Samuel F, Hansson, Oskar, Velakoulis, Dennis, Pantelis, Christos, and Santillo, Alexander
- Subjects
FOS: Psychology ,FOS: Clinical medicine ,170199 Psychology not elsewhere classified ,110319 Psychiatry (incl. Psychotherapy) ,Neuroscience - Abstract
Supplemental material, sj-pdf-1-anp-10.1177_00048674211058684 for Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives by Dhamidhu Eratne, Shorena Janelidze, Charles B Malpas, Samantha Loi, Mark Walterfang, Antonia Merritt, Ibrahima Diouf, Kaj Blennow, Henrik Zetterberg, Brandon Cilia, Cassandra Wannan, Chad Bousman, Ian Everall, Andrew Zalesky, Mahesh Jayaram, Naveen Thomas, Samuel F Berkovic, Oskar Hansson, Dennis Velakoulis, Christos Pantelis and Alexander Santillo in Australian & New Zealand Journal of Psychiatry
- Published
- 2021
- Full Text
- View/download PDF
15. Erratum: Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders (Brain (2020) 143 DOI: 10.1093/brain/awaa018)
- Author
-
Ducharme, Simon, Dols, Annemiek, Laforce, Robert, Devenney, Emma, Kumfor, Fiona, van den Stock, Jan, Dallaire-Théroux, Caroline, Seelaar, Harro, Gossink, Flora, Vijverberg, Everard, Huey, Edward, Vandenbulcke, Mathieu, Masellis, Mario, Trieu, Calvin, Onyike, Chiadi, Caramelli, Paulo, de Souza, Leonardo Cruz, Santillo, Alexander, Waldö, Maria Landqvist, Landin-Romero, Ramon, Piguet, Olivier, Kelso, Wendy, Eratne, Dhamidhu, Velakoulis, Dennis, Ikeda, Manabu, Perry, David, Pressman, Peter, Boeve, Bradley, Vandenberghe, Rik, Mendez, Mario, Azuar, Carole, Levy, Richard, Le Ber, Isabelle, Baez, Sandra, Lerner, Alan, Ellajosyula, Ratnavalli, Pasquier, Florence, Galimberti, Daniela, Scarpini, Elio, van Swieten, John, Hornberger, Michael, Rosen, Howard, Hodges, John, Diehl-Schmid, Janine, Pijnenburg, Yolande, Neurology, Psychiatry, Amsterdam Neuroscience - Neurodegeneration, Human genetics, and APH - Mental Health
- Abstract
The authors apologize for misspelling the last name of the author Ratnavalli Ellajosyula. This has now been corrected.
- Published
- 2020
16. Supplementary_Material – Supplemental material for Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
- Author
-
Pantelis, Christos, Jayaram, Mahesh, Hannan, Anthony J, Wesselingh, Robb, Nithianantharajah, Jess, Wannan, Cassandra MJ, Warda Taqdees Syeda, KH Christopher Choy, Zantomio, Daniela, Christopoulos, Arthur, Velakoulis, Dennis, and O’Brien, Terence J
- Subjects
FOS: Psychology ,FOS: Clinical medicine ,170199 Psychology not elsewhere classified ,110319 Psychiatry (incl. Psychotherapy) ,Neuroscience - Abstract
Supplemental material, Supplementary_Material for Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19 by Christos Pantelis, Mahesh Jayaram, Anthony J Hannan, Robb Wesselingh, Jess Nithianantharajah, Cassandra MJ Wannan, Warda Taqdees Syeda, KH Christopher Choy, Daniela Zantomio, Arthur Christopoulos, Dennis Velakoulis and Terence J O’Brien in Australian & New Zealand Journal of Psychiatry
- Published
- 2020
- Full Text
- View/download PDF
17. Online_Supp – Supplemental material for A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’ for psychiatrists and neurologists?
- Author
-
Dhamidhu Eratne, Loi, Samantha M, Nirbaanjot Walia, Farrand, Sarah, Li, Qiao-Xin, Shiji Varghese, Walterfang, Mark, Evans, Andrew, Mocellin, Ramon, Kunal Dhiman, Gupta, Veer, Malpas, Charles B, Collins, Steven, Masters, Colin L, and Velakoulis, Dennis
- Subjects
FOS: Psychology ,FOS: Clinical medicine ,170199 Psychology not elsewhere classified ,110319 Psychiatry (incl. Psychotherapy) ,Neuroscience - Abstract
Supplemental material, Online_Supp for A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’ for psychiatrists and neurologists? by Dhamidhu Eratne, Samantha M Loi, Nirbaanjot Walia, Sarah Farrand, Qiao-Xin Li, Shiji Varghese, Mark Walterfang, Andrew Evans, Ramon Mocellin, Kunal Dhiman, Veer Gupta, Charles B Malpas, Steven Collins, Colin L Masters and Dennis Velakoulis in Australian & New Zealand Journal of Psychiatry
- Published
- 2019
- Full Text
- View/download PDF
18. Development and validation of a screening questionnaire for psychogenic nonepileptic seizures
- Author
-
Trainor, David, Foster, Emma, Rychkova, Maria, Lloyd, Michael, Leong, Michelle, De Wei Wang, Albert, Velakoulis, Dennis, O'Brien, Terence, Kwan, Patrick, Loi, Samantha, and Malpas, Charles
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Diagnosis, Differential ,03 medical and health sciences ,Behavioral Neuroscience ,Epilepsy ,0302 clinical medicine ,Seizures ,Surveys and Questionnaires ,medicine ,Humans ,Psychogenic disease ,Prospective Studies ,030212 general & internal medicine ,Prospective cohort study ,Depression (differential diagnoses) ,Retrospective Studies ,business.industry ,Electroencephalography ,Retrospective cohort study ,medicine.disease ,Neurology ,Cohort ,Anxiety ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Somatization ,030217 neurology & neurosurgery - Abstract
Objective Epilepsy and psychogenic nonepileptic seizures (PNES) are serious conditions, associated with substantial morbidity and mortality. Although prompt diagnosis is essential, these conditions are frequently misdiagnosed, delaying appropriate treatment. We developed and validated the Anxiety, Abuse, and Somatization Questionnaire (AASQ), a quick and clinically practical tool to differentiate PNES from epilepsy. Method We retrospectively identified psychological variables that differentiated epilepsy from PNES in a discovery cohort of patients admitted to a video-electroencephalography monitoring (VEM) unit from 2002 to 2017. From these findings, we developed the AASQ and prospectively validated it in an independent cohort of patients with gold-standard VEM diagnosis. Results One thousand two hundred ninety-one patients were included in the retrospective study; mean age was 39.5 years (range: 18–99), 58% were female, 67% had epilepsy, and 33% had PNES. Psychometric data for 192 instrument items were reviewed, receiver operating characteristic curves were computed, and a 20-item AASQ was created. Prospective validation in 74 patients showed that a one-point increase in the AASQ score was associated with 11 times increase in the odds of having PNES compared with epilepsy. Low scores on the AASQ were associated with a low probability of PNES with a negative predictive value of 95%. Significance The AASQ is quick, inexpensive, and clinically useful for workup of seizure disorders. The AASQ excludes PNES with a high degree of confidence and can predict PNES with significance when combined with basic clinicodemographic variables. Future research will investigate diagnostic performance of the AASQ in relevant clinical subgroups, such as patients with comorbid epilepsy and PNES.
- Published
- 2020
19. APY766123_Appendix – Supplemental material for Alzheimer Disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms
- Author
-
Loi, Samantha M, Dhamidhu Eratne, Kelso, Wendy, Velakoulis, Dennis, and Looi, Jeffrey CL
- Subjects
FOS: Psychology ,FOS: Clinical medicine ,170199 Psychology not elsewhere classified ,110319 Psychiatry (incl. Psychotherapy) ,Neuroscience - Abstract
Supplemental material, APY766123_Appendix for Alzheimer Disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms by Samantha M Loi, Dhamidhu Eratne, Wendy Kelso, Dennis Velakoulis and Jeffrey CL Looi in Australasian Psychiatry
- Published
- 2018
- Full Text
- View/download PDF
20. APY766120_Appendix – Supplemental material for Huntington’s disease: Managing neuropsychiatric symptoms in Huntington’s disease
- Author
-
Loi, Samantha M, Walterfang, Mark, Velakoulis, Dennis, and Looi, Jeffrey CL
- Subjects
FOS: Psychology ,congenital, hereditary, and neonatal diseases and abnormalities ,FOS: Clinical medicine ,mental disorders ,170199 Psychology not elsewhere classified ,110319 Psychiatry (incl. Psychotherapy) ,nervous system diseases ,Neuroscience - Abstract
Supplemental material, APY766120_Appendix for Huntington’s disease: Managing neuropsychiatric symptoms in Huntington’s disease by Samantha M Loi, Mark Walterfang, Dennis Velakoulis and Jeffrey CL Looi in Australasian Psychiatry
- Published
- 2018
- Full Text
- View/download PDF
21. Multi-center MRI prediction models : Predicting sex and illness course in first episode psychosis patients
- Author
-
Nieuwenhuis, Mireille, Schnack, Hugo G., van Haren, Neeltje E., Kahn, René S., Lappin, Julia, Dazzan, Paola, Morgan, Craig, Reinders, Antje A., Gutierrez-Tordesillas, Diana, Roiz-Santiañez, Roberto, Crespo-Facorro, Benedicto, Schaufelberger, Maristela S., Rosa, Pedro G., Zanetti, Marcus V., Busatto, Geraldo F., McGorry, Patrick D., Velakoulis, Dennis, Pantelis, Christos, Wood, Stephen J., and Mourao-Miranda, Janaina
- Subjects
Neurology ,Cognitive Neuroscience ,Journal Article - Abstract
Structural Magnetic Resonance Imaging (MRI) studies have attempted to use brain measures obtained at the first-episode of psychosis to predict subsequent outcome, with inconsistent results. Thus, there is a real need to validate the utility of brain measures in the prediction of outcome using large datasets, from independent samples, obtained with different protocols and from different MRI scanners. This study had three main aims: 1) to investigate whether structural MRI data from multiple centers can be combined to create a machine-learning model able to predict a strong biological variable like sex; 2) to replicate our previous finding that an MRI scan obtained at first episode significantly predicts subsequent illness course in other independent datasets; and finally, 3) to test whether these datasets can be combined to generate multicenter models with better accuracy in the prediction of illness course. The multi-center sample included brain structural MRI scans from 256 males and 133 females patients with first episode psychosis, acquired in five centers: University Medical Center Utrecht (The Netherlands) (n = 67); Institute of Psychiatry, Psychology and Neuroscience, London (United Kingdom) (n = 97); University of São Paulo (Brazil) (n = 64); University of Cantabria, Santander (Spain) (n = 107); and University of Melbourne (Australia) (n = 54). All images were acquired on 1.5-Tesla scanners and all centers provided information on illness course during a follow-up period ranging 3 to 7 years. We only included in the analyses of outcome prediction patients for whom illness course was categorized as either “continuous” (n = 94) or “remitting” (n = 118). Using structural brain scans from all centers, sex was predicted with significant accuracy (89%; p
- Published
- 2017
22. Multi-center MRI prediction models:Predicting sex and illness course in first episode psychosis patients
- Author
-
Nieuwenhuis, Mireille, Schnack, Hugo G., van Haren, Neeltje E., Lappin, Julia, Morgan, Craig, Reinders, Antje A., Gutierrez-Tordesillas, Diana, Roiz-Santiañez, Roberto, Schaufelberger, Maristela S., Rosa, Pedro G., Zanetti, Marcus V., Busatto, Geraldo F., Crespo-Facorro, Benedicto, McGorry, Patrick D., Velakoulis, Dennis, Pantelis, Christos, Wood, Stephen J., Kahn, René S., Mourao-Miranda, Janaina, Dazzan, Paola, and Universidad de Cantabria
- Subjects
Neurology ,Cognitive Neuroscience - Abstract
Structural Magnetic Resonance Imaging (MRI) studies have attempted to use brain measures obtained at the first-episode of psychosis to predict subsequent outcome, with inconsistent results. Thus, there is a real need to validate the utility of brain measures in the prediction of outcome using large datasets, from independent samples, obtained with different protocols and from different MRI scanners. This study had three main aims: 1) to investigate whether structural MRI data from multiple centers can be combined to create a machine-learning model able to predict a strong biological variable like sex; 2) to replicate our previous finding that an MRI scan obtained at first episode significantly predicts subsequent illness course in other independent datasets; and finally, 3) to test whether these datasets can be combined to generate multicenter models with better accuracy in the prediction of illness course. The multi-center sample included brain structural MRI scans from 256 males and 133 females patients with first episode psychosis, acquired in five centers: University Medical Center Utrecht (The Netherlands) (n=67); Institute of Psychiatry, Psychology and Neuroscience, London (United Kingdom) (n=97); University of São Paulo (Brazil) (n=64); University of Cantabria, Santander (Spain) (n=107); and University of Melbourne (Australia) (n=54). All images were acquired on 1.5-Tesla scanners and all centers provided information on illness course during a follow-up period ranging 3 to 7years. We only included in the analyses of outcome prediction patients for whom illness course was categorized as either "continuous" (n=94) or "remitting" (n=118). Using structural brain scans from all centers, sex was predicted with significant accuracy (89%; p
- Published
- 2017
23. Longitudinal Partial Volume Correction in 2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Studies of Alzheimer Disease
- Author
-
Malpas, Charles B, Saling, Michael M, Velakoulis, Dennis, Desmond, Patricia, Hicks, Rodney J, OʼBrien, Terence J, and Alzheimer Disease Neuroimaging Initiative
- Subjects
Male ,Brain Mapping ,Aging ,Clinical Sciences ,Neurosciences ,Brain ,Reproducibility of Results ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Neurodegenerative ,Alzheimer's Disease ,Brain Disorders ,Alzheimer Disease Neuroimaging Initiative ,Nuclear Medicine & Medical Imaging ,Alzheimer Disease ,Fluorodeoxyglucose F18 ,Clinical Research ,Positron-Emission Tomography ,Neurological ,Acquired Cognitive Impairment ,Humans ,Female ,Dementia ,Radiopharmaceuticals ,Aged - Abstract
ObjectiveTo investigate partial volume correction (PVC) of 2-[F]-fluoro-2-deoxy-D-glucose positron emission tomography in Alzheimer disease in a longitudinal context.MethodsA total of 115 participants were included, including 55 controls, 53 patients with mild cognitive impairment, and 7 patients with dementia of the Alzheimer type. Imaging was performed at baseline and 24 months. Partial volume corrected vs uncorrected rates of longitudinal change were compared for mesial temporal and cortical regions of interest.ResultsPartial volume correction increased apparent uptake, and this effect was greater at 24 months compared with baseline. Partial volume correction decreased the rate of decline, causing an apparent increase in uptake at 24 months compared with baseline. This effect was correlated with the structural atrophy.ConclusionsThese findings suggest that applying PVC in a longitudinal context in Alzheimer disease might produce unpredictable results. Accordingly, both PVC corrected and uncorrected data should be reported to ensure that the results are physiologically plausible.
- Published
- 2015
24. Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment
- Author
-
Malpas, Charles B, Saling, Michael M, Velakoulis, Dennis, Desmond, Patricia, O'Brien, Terence J, Alzheimer's Disease Neuroimaging Initiative, and Abbate, Carlo
- Subjects
Male ,cognition ,Aging ,Clinical Trials and Supportive Activities ,Clinical Sciences ,tau Proteins ,Neuropsychological Tests ,Neurodegenerative ,Alzheimer's Disease ,cerebrospinal fluid ,Databases ,mild cognitive impairment ,Clinical Research ,Behavioral and Social Science ,80 and over ,Acquired Cognitive Impairment ,Humans ,Learning ,2.1 Biological and endogenous factors ,Cognitive Dysfunction ,Amyloid-β ,tau ,Phosphorylation ,Aetiology ,Factual ,Aged ,Amyloid beta-Peptides ,Neurology & Neurosurgery ,Alzheimer's Disease Neuroimaging Initiative ,Neurosciences ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Middle Aged ,Peptide Fragments ,Brain Disorders ,Neurological ,Regression Analysis ,Female ,Dementia ,Mental health ,Cognitive Sciences ,Amyloid-beta ,Biomarkers - Abstract
Alzheimer's disease (AD) is characterized by two primary pathologies: tau-related neurofibrillary tangles and the extracellular accumulation of amyloid-β (Aβ). The development of these pathologies is topologically distinct early in the disease, with Aβ beginning to accumulate as a diffuse, neocortical pathology, while tau-related pathology begins to form in mesial temporal regions. This study investigated the hypothesis that, by virtue of this distinction, there exist preferential associations between the primary pathologies and aspects of the cognitive phenotype. We investigated the relationship between cerebrospinal fluid (CSF) biomarkers for tau and Aβ pathologies with neurocognitive measures in 191 patients with mild cognitive impairment (MCI). Participants completed cognitive tests of new learning, information processing speed, and working memory. Separate regression models were computed and then followed up with mediation analyses to examine the predictive status of CSF biomarkers. The effect of Aβ on learning was mediated by phospho-tau (p = 0.008). In contrast, Aβ had a direct effect on information processing speed that was not mediated by phospho-tau (p = 0.59). No predictors were significant for working memory. This study provided evidence for a differential relationship of Aβ and phospho-tau pathologies on the neurocognitive phenotype of MCI. This supports the proposition that these primary AD pathologies maximally affect different aspects of cognition, and has potential implications for cognitive assessments and the use of biomarkers in disease-modifyingtherapeutic trials.
- Published
- 2015
25. Divergent Effects of First- and Second-generation Antipsychotics on Cortical Thickness in First-episode Psychosis
- Author
-
Proffitt, Tina, Wood, Stephen J., Pantelis, Christos, McGorry, Patrick D., Velakoulis, Dennis, Dwyer, Dominic B., Ansell, Brendan R. E., Brewer, Warrick, and BORA, İBRAHİM EMRE
- Published
- 2014
26. AUSSIE – the Australian United States Scandinavian Imaging Exchange: an innovative virtual integrated health research network embedded in health care
- Author
-
Looi, Jeffrey C.L., Velakoulis, Dennis, Walterfang, Mark, Georgiou-Karistianis, Nellie, Macfarlane, Matthew D., Power, Brian D., Nilsson, Christer, Styner, Martin, Thompson, Paul M., van Westen, Danielle, Wilkes, Fiona A., and Wahlund, Lars-Olof
- Subjects
education ,Article - Abstract
To describe the development, design and function of an innovative international clinical research network for neuroimaging research, based in Australia, within a joint state health service/medical school. This Australian, US, Scandinavian Imaging Exchange (AUSSIE) network focuses upon identifying neuroimaging biomarkers for neuropsychiatric and neurodegenerative disease.We describe a case study of the iterative development of the network, identifying characteristic features and methods which may serve as potential models for virtual clinical research networks. This network was established to analyse clinically-derived neuroimaging data relevant to neuropsychiatric and neurodegenerative disease, specifically in relation to subcortical brain structures.The AUSSIE network has harnessed synergies from the individual expertise of the component groups, primarily clinical neuroscience researchers, to analyse a variety of clinical data.AUSSIE is an active virtual clinical research network, analogous to a connectome, which is embedded in health care and has produced significant research, advancing our understanding of neuropsychiatric and neurodegenerative disease through the lens of neuroimaging.
- Published
- 2014
- Full Text
- View/download PDF
27. Shape analysis of the hippocampus in Alzheimer’s disease and subtypes of frontotemporal lobar degeneration
- Author
-
Lindberg, Olof, Walterfang, Mark, Looi, Jeffrey C.L., Malykhin, Nikolai, Östberg, Per, Zandbelt, Bram, Styner, Martin, Velakoulis, Dennis, Örndahl, Eva, Cavallin, Lena, and Wahlund, Lars-Olof
- Subjects
Adult ,Male ,CA2 Region, Hippocampal ,nutritional and metabolic diseases ,Middle Aged ,CA3 Region, Hippocampal ,Hippocampus ,Magnetic Resonance Imaging ,Article ,nervous system diseases ,nervous system ,Alzheimer Disease ,mental disorders ,Dentate Gyrus ,Humans ,Dementia ,Female ,Primary Progressive Nonfluent Aphasia ,Atrophy ,Frontotemporal Lobar Degeneration ,CA1 Region, Hippocampal ,Aged - Abstract
Hippocampal pathology is central to Alzheimer's disease (AD) and other forms of dementia such as frontotemporal lobar degeneration (FTLD). Autopsy studies have shown that certain hippocampal subfields are more vulnerable than others to AD and FTLD pathology, in particular the subiculum and cornu ammonis 1 (CA1). We conducted shape analysis of hippocampi segmented from structural T1 MRI images on clinically diagnosed dementia patients and controls. The subjects included 19 AD and 35 FTLD patients [13 frontotemporal dementia (FTD), 13 semantic dementia (SD), and 9 progressive nonfluent aphasia (PNFA)] and 21 controls. Compared to controls, SD displayed severe atrophy of the whole left hippocampus. PNFA and FTD also displayed atrophy on the left side, restricted to the hippocampal head in FTD. Finally, AD displayed most atrophy in left hippocampal body with relative sparing of the hippocampal head. Consistent with neuropathological studies, most atrophic deformation was found in CA1 and subiculum areas in FTLD and AD.
- Published
- 2012
28. Shape alterations in the striatum in chorea-acanthocytosis
- Author
-
Evans, Andrew, Looi, Jeffrey Chee Leong, Walker, Ruth H., Niethammer, Marc, Kotschet, Katya, Rodrigues, Guilherme R., Velakoulis, Dennis, Hughes, Andrew, Styner, Martin, Walterfang, Mark, and Danek, Adrian
- Subjects
mental disorders - Abstract
Chorea-acanthocytosis (ChAc) is an uncommon autosomal recessive disorder due to mutations of the VPS13A gene, which encodes for the membrane protein chorein. ChAc presents with progressive limb and orobuccal chorea, but there is often a marked dysexecutive syndrome. ChAc may first present with neuropsychiatric disturbance such as obsessive-compulsive disorder (OCD), suggesting a particular role for disruption to striatal structures involved in non-motor frontostriatal loops, such as the head of the caudate nucleus. Two previous studies have suggested a marked reduction in volume in the caudate nucleus and putamen, but did not examine morphometric change.
- Published
- 2011
- Full Text
- View/download PDF
29. STRUCTURAL BRAIN CHANGES IN SCHIZOPHRENIA AND BIPOLAR DISORDER
- Author
-
Pantelis, Christos, Bora, Emre, Wood, Stephen, Takahashi, Tsutomu, Alison Yung, Phillips, Lisa, Walterfang, Mark, Frangou, Sophia, Malhi, Gin, Velakoulis, Dennis, Suzuki, Michio, Mcgorry, Patrick, and Yuecel, Murat
- Published
- 2010
30. Should we redefine the concept of endophenotype in schizophrenia?
- Author
-
Pantelis, Christos, Wood, Stephen J., Velakoulis, Dennis, Testa, Renee, Fontenelle, Leonardo F., and Yücel, Murat
- Published
- 2010
31. Topiramate for Abnormal Eating Behaviour in Frontotemporal Dementia
- Author
-
Singam, Colin, Walterfang, Mark, Mocellin, Ramon, Evans, Andrew, and Velakoulis, Dennis
- Subjects
Adult ,Male ,topiramate ,digestive, oral, and skin physiology ,executive dysfunction ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Fructose ,General Medicine ,hyperphagia ,Neuropsychology and Physiological Psychology ,Neurology ,Frontotemporal Dementia ,mental disorders ,Humans ,Anticonvulsants ,Clinical Note ,Neurology (clinical) ,Binge-Eating Disorder ,RC321-571 - Abstract
Topiramate is a sulfamate-substituted monosaccharide anticonvulsant that is associated with anorexia and weight loss and has been used to treat binge eating disorder and bulimia nervosa. This report describes a man with frontotemporal dementia, behavioural variant, associated with abnormal eating behaviour which appeared to respond to topiramate. We review the physiological basis of abnormal eating behaviour in frontotemporal dementia and explore possible mechanisms of action by which topiramate may modify eating behaviour in this condition.
- Published
- 2013
32. NEUROANATOMICAL PREDICTORS OF FUNCTIONAL OUTCOME IN THE AT-RISK MENTAL STATE
- Author
-
Reniers, Renate L., Lin, Ashleigh, Alison Yung, Koutsouleris, Nikolaos, Nelson, Barnaby, Velakoulis, Dennis, Pantelis, Christos, and Wood, Stephen
33. STRUCTURAL BRAIN CHANGES DURING TRANSITION-TO-ILLNESS IN INDIVIDUALS AT RISK FOR SCHIZOPHRENIA: FINDINGS FROM THE MELBOURNE ULTRA-HIGH RISK STUDIES
- Author
-
Pantelis, Christos, Wood, Stephen, Takahashi, Tsutomu, Velakoulis, Dennis, Phillips, Lisa, Fornito, Alex, Walterfang, Mark, Yucel, Murat, Suzuki, Michio, Mcgorry, Patrick, and Alison Yung
34. Shape Abnormalities of the Caudate Nucleus Correlate with Poorer Gait and Balance: Results from a Subset of the LADIS Study
- Author
-
Örndahl, Eva, Macfarlane, Matthew D., Bäzner, Hansjörg, Garde, Ellen, Looi, Jeffrey C.L., Waldemar, Gunhild, Styner, Martin, Velakoulis, Dennis, Crisby, Milita, Erkinjuntti, Timo, Spulber, Gabriela, Walterfang, Mark, Wallin, Anders, Wahlund, Lars-Olof, Hennerici, Michael G., and Blahak, Christian
- Subjects
nervous system ,sense organs ,10. No inequality - Abstract
Functional deficits seen in several neurodegenerative disorders have been linked with dysfunction in fronto-striatal circuits and with associated shape alterations in striatal structures. The severity of visible white matter changes (WMC) on MRI has been found to correlate with poorer performance on measures of gait and balance. This study aimed to determine whether striatal volume and shape changes were correlated with gait dysfunction.
35. Baseline Grey Matter Volume of Non-Transitioned 'Ultra High Risk' Cases With and Without Attenuated Psychotic Symptoms at Long Term Follow Up
- Author
-
Cropley, Vanessa L., Wood, Stephen J., Lin, Ashleigh, Nelson, Barnaby, Renate Reniers, Yung, Alison R., Bartholomeusz, Cali F., Klauser, Paul, Velakoulis, Dennis, Mcgorry, Patrick, and Pantelis, Christos
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.